SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Cronos is an institutional-grade, high-performance, EVM-compatible Layer-1 blockchain built on the Cosmos SDK and integrated with the Inter-Blockchain Communication (IBC) protocol, designed as the backbone for open, compliant, and AI-accessible tokenized markets. It supports up to 60,000 transactions per second (TPS), 500ms block times, instant finality, and sub-$0.01 fees via Proof of Authority consensus.

Crypto.com Coin

Crypto.com Coin (CRO) is trending as investors debate its long-term viability amid ongoing concerns over token dilution, regulatory developments, and the launch of new ecosystem tools. The community remains deeply divided, with some users highlighting potential upside from institutional interest and new product integrations, while others express frustration over historical price performance and perceived management decisions.

Aurora Innovation, Inc. engages in the design and development of automobile hardware, software, and provision of data services. It offers the Aurora Driver which allows a vehicle to drive itself. The company was founded by Christopher Urmson, Sterling Anderson and James Andrew Bagnell in 2017 and is headquartered in Pittsburgh, PA.

Aurora Innovation Inc - Ordinary Shares - Class A

Aurora Innovation is trending as the community closely monitors the company's progress toward commercial scaling and its upcoming second-generation driverless truck fleet. Investors are actively discussing the significance of recent partnership announcements and management's execution on production milestones, while debating the impact of short interest and overall market volatility.

ProShares Trust II - ProShares Ultra Silver 2x Shares

ProShares Ultra Silver

ProShares Ultra Silver is attracting intense community interest as traders debate whether the recent volatility represents a classic commodity bubble or a strategic buying opportunity driven by industrial silver shortages and geopolitical tension. Investors remain sharply divided, with bulls pointing to long-term supply deficits and potential short-squeeze setups, while bears warn of the risks associated with the ETF's daily leveraged decay and broader sensitivity to shifting interest rate expectations and USD fluctuations.

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

AMGEN Inc.

AMGN is trending as investor interest in their cardiometabolic pipeline remains high, while community discussion centers on potential M&A speculation and the company's competitive positioning in the weight-loss drug market. Traders are actively monitoring technical price levels and volume shifts as the stock navigates broader sector volatility and expectations for future pipeline readouts.

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Amarin Corp - ADR

Amarin is trending as investors closely await a pivotal Supreme Court ruling on its litigation with Hikma, which could significantly impact its U.S. competitive position and future M&A prospects. While some in the community focus on long-term value through pipeline developments and potential buyouts, many remain frustrated by the stock's stagnant price action and the ongoing legal overhang.

NioCorp Developments Ltd. engages in the evaluation, acquisition, exploration, and development of mineral deposits. It focuses on a super alloy materials project in Nebraska for producing niobium, scandium, and titanium. The company was founded on February 27, 1987, and is headquartered in Centennial, CO.

NioCorp Developments Ltd

NioCorp Developments is currently under the spotlight as investors await a definitive Feasibility Study and updates on significant EXIM bank financing. While community sentiment remains polarized between long-term optimism regarding the project's strategic value in the domestic critical minerals supply chain and frustration over recurring timeline delays, recent developments like the potential Traxys offtake agreement have kept the stock at the center of active retail and institutional discussion.

Ginkgo Bioworks Holdings, Inc. engages in developing biological engineering products and custom microbes. Its platform enables biotechnology applications across diverse markets, from food, agriculture, industrial chemicals, and pharmaceuticals. It operates through the Cell Engineering and Biosecurity segments. The Cell Engineering segment includes end-to-end cell engineering solutions and cell engineering tools offerings for biological research and development. The Biosecurity segment focuses on biomonitoring and bioinformatics support services, offered to both government and non-government customers through its Canopy and Horizon offerings. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.

Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A

Ginkgo Bioworks is gaining attention as investors and the community debate its shift toward an autonomous laboratory model supported by federal-scale AI initiatives like the Genesis Mission. While many followers are expressing skepticism due to the company's historical financial performance and reliance on cash reserves, bullish participants are highlighting potential long-term strategic value in its cloud-lab infrastructure and alignment with national biosecurity priorities.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is seeing intensified community focus as its QNX software gains traction as the foundational layer for Physical AI, robotics, and intelligent vehicles following design wins with Axera Semiconductor. Investors are actively discussing the potential impact of the upcoming Alloy Kore platform launch, weighing the long-term strategic integration of QNX into major silicon stacks against recent volatility and executive equity activity.

Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development include vaccines for chronic hepatitis B, ebola, and dengue virus. The company was founded by Philippe Pouletty on December 4, 2003 and is headquartered in Paris, France.

Abivax - ADR

ABVX is seeing significant volatility following a sharp sell-off triggered by clinical data concerns, with active community debate centering on whether the market's reaction was an overreaction to misunderstood safety signals or a genuine risk to the company's valuation. Investors are closely monitoring the stock for potential recovery as analysts offer mixed targets and speculators position themselves for potential M&A activity, viewing the current price action as a key inflection point.

Solana is a high-performance Layer 1 blockchain designed for mass adoption by providing a fast, secure, and low-cost environment for decentralized applications. It distinguishes itself by scaling globally without the use of complex sharding or multiple layers, instead maintaining a single, unified ledger to avoid liquidity fragmentation. This architecture allows it to process thousands of transactions per second with sub-second finality, often at a cost of less than a penny per transaction.  The network operates on a unique hybrid model that combines Proof of Stake with an innovation called Proof of History, which functions as a decentralized clock to timestamp transactions. This system reduces the need for constant node communication, allowing the Sealevel engine to run non-conflicting smart contracts in parallel across multiple CPU cores. Further efficiency is gained through the Gulf Stream protocol, which reduces confirmation times by forwarding transactions to validators before the current block is finished.  Founded in 2017 by Anatoly Yakovenko, Solana is now supported by the Switzerland-based Solana Foundation and significant institutional investors like Andreessen Horowitz and Polychain Capital. The platform’s native token, SOL, serves as the primary currency for paying transaction fees, participating in network governance, and securing the system through staking.   Solana has also seen significant institutional adoption ranging from spot Solana ETFs to major partnerships including Visa's 2025 launch of USDC settlement on the network and the tokenization of public equity by firms like Galaxy Digital.

Solana

Solana is trending as traders debate its market structure while monitoring crucial support and resistance levels, with community discourse heavily focused on price recovery potential and the role of staking in long-term accumulation. Market participants are actively comparing Solana's transaction efficiency and ecosystem utility to other major assets while gauging broader macroeconomic catalysts that could drive a potential rotation into crypto.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


bullsnhorns2

bullsnhorns2